Literature DB >> 1968639

Enhanced polymerization of recombinant human deoxyhemoglobin beta 6 Glu----Ile.

V Baudin-Chich1, J Pagnier, M Marden, B Bohn, N Lacaze, J Kister, O Schaad, S J Edelstein, C Poyart.   

Abstract

Polymerization of the deoxy form of sickle cell hemoglobin (Hb S; beta 6 Glu----Val) involves both hydrophobic and electrostatic intermolecular contacts. These interactions drive the mutated molecules into long fibrous rods composed of seven pairs of strands. X-ray crystallography of Hb S and electron microscopy image reconstruction of the fibers have revealed the remarkable complementarity between one of the beta 6 valines of each molecule (the donor site) and an acceptor site at the EF corner of a neighboring tetramer. This interaction constitutes the major lateral contact between the two strands in a pair. To estimate the relative importance of this key hydrophobic contact in polymer formation we have generated a polymerizing Hb with isoleucine at the beta 6 position (beta E6I) by site-directed mutagenesis. The mutated beta chains were produced in Escherichia coli and reassembled into functional tetramers with native alpha chains. Compared to native Hb S, the beta E6I mutant polymerizes faster and with a shortened delay time in 1.8 M phosphate buffer, indicating an increased stability of the nuclei preceding fiber growth. The solubility of the beta E6I mutant Hb is half that of native Hb S. Computer modeling of the donor-acceptor interaction shows that the presence of an isoleucine side chain at the donor site induces increased contacts with the receptor site and an increased buried surface area, in agreement with the higher hydrophobicity of the isoleucine residue. The agreement between the predicted and experimental differences in solubility suggests that the transfer of the beta 6 valine or isoleucine side chain from water to a hydrophobic environment is sufficient to explain the observations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968639      PMCID: PMC53580          DOI: 10.1073/pnas.87.5.1845

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis.

Authors:  K L Nakamaye; F Eckstein
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

2.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

3.  Solvation energy in protein folding and binding.

Authors:  D Eisenberg; A D McLachlan
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

4.  Hemoglobin Machida [beta 6 (A3) Glu replaced by Gln], a new abnormal hemoglobin discovered in a Japanese family: structure, function and biosynthesis.

Authors:  T Harano; K Harano; S Ueda; S Shibata; K Imai; M Seki
Journal:  Hemoglobin       Date:  1982       Impact factor: 0.849

5.  Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution.

Authors:  E A Padlan; W E Love
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

6.  A new approach (cyano-transfer) for cyanogen bromide activation of Sepharose at neutral pH, which yields activated resins, free of interfering nitrogen derivatives.

Authors:  J Kohn; M Wilchek
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

7.  Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo.

Authors:  A Mozzarelli; J Hofrichter; W A Eaton
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

8.  Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli.

Authors:  K Nagai; M F Perutz; C Poyart
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.

Authors:  N Monplaisir; G Merault; C Poyart; M D Rhoda; C Craescu; M Vidaud; F Galacteros; Y Blouquit; J Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Modification of human hemoglobin by glutathione. III. Perturbations of hemoglobin conformation analyzed by computer modeling.

Authors:  S J Wodak; J L De Coen; S J Edelstein; H Demarne; Y Beuzard
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

View more
  5 in total

1.  Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins.

Authors:  M T Bihoreau; V Baudin; M Marden; N Lacaze; B Bohn; J Kister; O Schaad; A Dumoulin; S J Edelstein; C Poyart
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

2.  Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility.

Authors:  Ming F Tam; Tsuey Chyi S Tam; Virgil Simplaceanu; Nancy T Ho; Ming Zou; Chien Ho
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

3.  Recombinant human sickle hemoglobin expressed in yeast.

Authors:  J J Martin de Llano; O Schneewind; G Stetler; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

4.  Heme as an optical probe of a conformational transition of ovine recPrP.

Authors:  Christine Pato; Chantal Célier; Human Rezaei; Jeanne Grosclaude; Michael C Marden
Journal:  Protein Sci       Date:  2004-03-09       Impact factor: 6.725

5.  Mutational analysis of phenylalanine beta 85 in the valine beta 6 acceptor pocket during hemoglobin S polymerization.

Authors:  K Adachi; L R Reddy; K S Reddy; S Surrey
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.